PATENT CLAIM ANALYSIS

Application Number: 16025652
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "094300"]

Abstract:
The invention provides reagents and methods for enzyme replacement therapy using chemically modified species of human cystathionine β-synthase (CBS) to treat homocystinuria and other related diseases and disorders.

Claim (Index 20):
The method of  claim 19 , wherein the level of homocysteine is reduced by about 80% compared to prior to administering.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.06897
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15235355', '14687389', '13803804', '15492671', '15774755']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8655002033743565
- 35 USC 102 Novelty (BERT): 0.6182677582159625
- Combined Prediction Score: 0.8407769588585171
- Mean Citation Score: 653.751418
- Max Citation Score: 741.7077
- Similarity Product: 492.63836979927424

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test